{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:46:35Z","timestamp":1791117995095,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.coi.2010.12.014","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T04:17:34Z","timestamp":1296015454000},"page":"258-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Immune defence against EBV and EBV-associated disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Heather M","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B","family":"Rickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2010.12.014_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0010","doi-asserted-by":"crossref","first-page":"e12926","DOI":"10.1371\/journal.pone.0012926","article-title":"Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage","volume":"5","author":"Greenough","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2010.12.014_bib0015","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1128\/JVI.00141-09","article-title":"Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection","volume":"83","author":"Sauce","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2010.12.014_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2249.2008.03699.x","article-title":"Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis","volume":"153","author":"Scherrenburg","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"Adhikary","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2010.12.014_bib0030","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.0902850","article-title":"Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors","volume":"184","author":"Merlo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0035_1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.ppat.0040027","article-title":"Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma","volume":"4","author":"Strowig","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2010.12.014_bib0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.25.022106.141651","article-title":"Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules","volume":"25","author":"Ma","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0045_1","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood-2009-09-238832","article-title":"Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets","volume":"116","author":"Hislop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0050","first-page":"2976","article-title":"Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency","volume":"119","author":"Snow","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2010.12.014_bib0055_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.semcancer.2008.10.008","article-title":"Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products","volume":"18","author":"Ressing","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.coi.2010.12.014_bib0060","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.20070256","article-title":"A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates","volume":"204","author":"Hislop","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2010.12.014_bib0065","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.4049\/jimmunol.0803218","article-title":"Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation","volume":"182","author":"Horst","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0070","doi-asserted-by":"crossref","first-page":"e1000490","DOI":"10.1371\/journal.ppat.1000490","article-title":"Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle","volume":"5","author":"Croft","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2010.12.014_bib0075","doi-asserted-by":"crossref","first-page":"e1000255","DOI":"10.1371\/journal.ppat.1000255","article-title":"The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation","volume":"5","author":"Zuo","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2010.12.014_bib0080","article-title":"The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting MHC class I molecules trafficking on both the exocytic and endocytic pathways","author":"Zuo","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2010.12.014_bib0085","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/JVI.01946-07","article-title":"The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function","volume":"82","author":"Zuo","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2010.12.014_bib0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.chom.2009.03.003","article-title":"Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells","volume":"5","author":"Nachmani","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2010.12.014_bib0095","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4049\/jimmunol.0802686","article-title":"Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0100","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1182\/blood-2009-02-203687","article-title":"Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation","volume":"113","author":"Smith","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0105","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/sj.onc.1210946","article-title":"The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy","volume":"27","author":"Lee","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.coi.2010.12.014_bib0110","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.0713607","article-title":"Cyclical expression of EBV latent membrane protein 1 in EBV-transformed B cells underpins heterogeneity of epitope presentation and CD8+ T cell recognition","volume":"182","author":"Brooks","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0115","doi-asserted-by":"crossref","first-page":"e1001151","DOI":"10.1371\/journal.ppat.1001151","article-title":"Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation","volume":"6","author":"Apcher","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2010.12.014_bib0120","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01369-08","article-title":"mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1","volume":"83","author":"Apcher","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2010.12.014_bib0125_1","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1073\/pnas.0801968105","article-title":"Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition","volume":"105","author":"Tellam","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2010.12.014_bib0130","doi-asserted-by":"crossref","first-page":"e1000699","DOI":"10.1371\/journal.ppat.1000699","article-title":"T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display","volume":"5","author":"Mackay","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2010.12.014_bib0135","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1073\/pnas.0909448107","article-title":"Nuclear location of an endogenously expressed antigen. EBNA1, restricts access to macroautophagy and the range of CD4 epitope display","volume":"107","author":"Leung","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2010.12.014_bib0140","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/ijc.23845","article-title":"Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1","volume":"123","author":"Heller","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coi.2010.12.014_bib0145","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/ijc.24014","article-title":"Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses","volume":"124","author":"Moormann","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coi.2010.12.014_bib0150","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1073\/pnas.0813320106","article-title":"Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"106","author":"Fogg","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2010.12.014_bib0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00262-007-0427-8","article-title":"CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients","volume":"57","author":"Lin","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.coi.2010.12.014_bib0160_1","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0140-6736(05)66780-3","article-title":"Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma","volume":"365","author":"Diepstra","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2010.12.014_bib0165","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0170","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.0915054107","article-title":"HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma","volume":"107","author":"Hjalgrim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2010.12.014_bib0175","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2008-06-162883","article-title":"A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis","volume":"112","author":"Brennan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0180_1","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI32377","article-title":"HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection","volume":"117","author":"McAulay","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2010.12.014_bib0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajhg.2009.07.007","article-title":"Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3","volume":"85","author":"Tse","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2010.12.014_bib0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ng.601","article-title":"A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci","volume":"42","author":"Bei","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2010.12.014_bib0195_1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/TP.0b013e3181d7c424","article-title":"Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up","volume":"90","author":"Haque","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2010.12.014_bib0205","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0210","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2010-06-289991","article-title":"Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects","volume":"116","author":"Melenhorst","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0215","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1182\/blood-2010-04-281873","article-title":"Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes","volume":"116","author":"Barker","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.blre.2009.02.001","article-title":"Umbilical cord blood transplantation: pros, cons and beyond","volume":"23","author":"Stanevsky","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.coi.2010.12.014_bib0225","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0230","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/CJI.0b013e3181f3cbf4","article-title":"Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma","volume":"33","author":"Louis","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.coi.2010.12.014_bib0235","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.4049\/jimmunol.0803572","article-title":"Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease","volume":"182","author":"McAulay","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0240_1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0245","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy","volume":"2","author":"Adhikary","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2010.12.014_bib0250","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.4049\/jimmunol.177.6.3746","article-title":"A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells","volume":"177","author":"Taylor","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0255","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood-2008-12-194043","article-title":"CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells","volume":"114","author":"Long","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0260","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2010-06-292268","article-title":"A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy","volume":"116","author":"Fox","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0265","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4049\/jimmunol.180.3.1643","article-title":"EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines","volume":"180","author":"Haigh","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2010.12.014_bib0270","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/0008-5472.CAN-07-3212","article-title":"Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells","volume":"68","author":"Kobayashi","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.coi.2010.12.014_bib0275","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1349-7006.2008.00852.x","article-title":"Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells","volume":"99","author":"Demachi-Okamura","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.coi.2010.12.014_bib0280","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00262-009-0789-1","article-title":"A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation","volume":"59","author":"Uhlin","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.coi.2010.12.014_bib0285","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood-2010-03-274076","article-title":"Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders","volume":"116","author":"Jones","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0290","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2009-08-236356","article-title":"Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells","volume":"115","author":"Moosmann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0295","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2007-05-091280","article-title":"Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer","volume":"110","author":"Bollard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0300","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/0008-5472.CAN-03-2196","article-title":"Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine","volume":"64","author":"Duraiswamy","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.coi.2010.12.014_bib0305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/JVI.01303-09","article-title":"Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine","volume":"84","author":"Lutzky","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2010.12.014_bib0310","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1128\/JVI.78.2.768-778.2004","article-title":"Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma","volume":"78","author":"Taylor","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2010.12.014_bib0315","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/mt.2009.34","article-title":"Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7","volume":"17","author":"Vera","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2010.12.014_bib0320","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/leu.2010.75","article-title":"Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma\/leukemia effects and safety","volume":"24","author":"Hoyos","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.coi.2010.12.014_bib0325_1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2008-05-157222","article-title":"Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients","volume":"113","author":"Louis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0330","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","article-title":"PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma","volume":"111","author":"Yamamoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0335","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","article-title":"The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape","volume":"221","author":"Aldinucci","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.coi.2010.12.014_bib0340","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1600-6143.2007.01796.x","article-title":"Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders","volume":"7","author":"Gandhi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2010.12.014_bib0345","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/JVI.00239-09","article-title":"Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression","volume":"83","author":"Smith","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2010.12.014_bib0350","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2009-03-209650","article-title":"T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model","volume":"113","author":"Di Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0355","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/CJI.0b013e318177092b","article-title":"Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor","volume":"31","author":"Foster","year":"2008","journal-title":"J Immunother"},{"key":"10.1016\/j.coi.2010.12.014_bib0360","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1182\/blood-2009-07-228387","article-title":"Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease","volume":"114","author":"Brewin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0365","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-07-230482","article-title":"Generation of Epstein-Barr-virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)","author":"De Angelis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.coi.2010.12.014_bib0370_1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2010.12.014_bib0375","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults","volume":"25","author":"Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2010.12.014_bib0380","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2010.12.014_bib0385","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2353\/ajpath.2008.071186","article-title":"CD34+ cord blood cell-transplanted Rag2\u2212\/\u2212 gamma(c)\u2212\/\u2212 mice as a model for Epstein-Barr virus infection","volume":"173","author":"Cocco","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coi.2010.12.014_bib0390_1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20081720","article-title":"Priming of protective T cell responses against virus-induced tumors in mice with human immune system components","volume":"206","author":"Strowig","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2010.12.014_bib0395_1","doi-asserted-by":"crossref","first-page":"13022","DOI":"10.1073\/pnas.1000475107","article-title":"Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice","volume":"107","author":"Shultz","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791510002165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791510002165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:35:31Z","timestamp":1760603731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791510002165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0952791510002165"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2010.12.014","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune defence against EBV and EBV-associated disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2010.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}